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Abstract
Background: In the presence of type 2 diabetes (T2DM) or coronary heart disease (CHD),
depression is under diagnosed and under treated despite being associated with worse clinical
outcomes. Our earlier pilot study demonstrated that it was feasible, acceptable and affordable for
practice nurses to extend their role to include screening for and monitoring of depression
alongside biological and lifestyle risk factors. The current study will compare the clinical outcomes
of our model of practice nurse-led collaborative care with usual care for patients with depression
and T2DM or CHD.
Methods: This is a cluster-randomised intervention trial. Eighteen general practices from regional
and metropolitan areas agreed to join this study, and were allocated randomly to an intervention
or control group. We aim to recruit 50 patients with co-morbid depression and diabetes or heart
disease from each of these practices. In the intervention group, practice nurses (PNs) will be
trained for their enhanced roles in this nurse-led collaborative care study. Patients will be invited
to attend a practice nurse consultation every 3 months prior to seeing their usual general
practitioner. The PN will assess psychological, physiological and lifestyle parameters then work
with the patient to set management goals. The outcome of this assessment will form the basis of a
GP Management Plan document. In the control group, the patients will continue to receive their
usual care for the first six months of the study before the PNs undergo the training and switch to
the intervention protocol. The primary clinical outcome will be a reduction in the depression score.
The study will also measure the impact on physiological measures, quality of life and on patient
attitude to health care delivered by practice nurses.
Conclusion: The strength of this programme is that it provides a sustainable model of chronic
disease management with monitoring and self-management assistance for physiological, lifestyle and
psychological risk factors for high-risk patients with co-morbid depression, diabetes or heart
disease. The study will demonstrate whether nurse-led collaborative care achieves better
outcomes than usual care.
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Background
Coronary heart disease (CHD) and type 2 diabetes melli-
tus (T2DM) are both major causes of disability. The inci-
dence of T2DM is now reaching epidemic proportions in
Australia [1] and overseas [2], particularly as the popula-
tion ages and becomes more obese [3]. Within 20 years
diabetes will become the leading contributor to the over-
all burden of disease in Australia [4] with Australian
health care expenditure projected to increase to $7 billion
by 2023 [5]. CHD already affects over 300,000 people in
Australia and remains the most common cause of death
[6]. Both diabetes and heart disease are associated with a
number of serious complications, each with its own cost.
There is evidence that the presence of depression in
patients with CHD or T2DM leads to increased morbidity
and mortality [7,8], but co-morbid depression is often
missed in routine consultations within general practices
[9]. One difficulty is that the traditional model used by
general practices is one in which visits to the general prac-
titioner (GP) are initiated by patients when they feel that
their needs warrant a consultation. Such visits are usually
episodic and cease when the immediate symptoms are
relieved. Consequently, such patients miss out on regular
monitoring of their chronic disease so that risk factors go
unrecognised [9].
A collaborative model is one in which the care delivery
has multiple components that address these problems
[10] and has been shown to have good results in treating
depression [11]. It relies on a case manager to coordinate
that care. Hickie and McGorry [12] summarise the
planned episodes of care that include:
• Use of evidence based guidelines;
￿ Systematic screening and monitoring of risk factors;
￿ Timetabled recall visits;
￿ New or adjusted roles for team members;
￿ Information support for the clinician;
￿ Enhanced patient self-management;
￿ Identified case manager to coordinate care;
￿ A means of effective communication between all
members of the care team; and
￿ Audit information for the practice.
The True Blue study described in this paper extends an
exploratory trial to adapt the successful IMPACT model of
collaborative care for depression in the USA [10] to an
Australian primary health care setting. The case manager
in this study is the practice nurse (PN). The model of prac-
tice nurse-led collaborative care was demonstrated in six
general practices in rural southern Australia, with 332
patients recruited [13]. In this exploratory trial a practice
nurse training programme was developed for chronic dis-
ease management, introducing depression screening and
counselling techniques to assist with self-management.
Electronically based multi-purpose tools were designed
and tested to allow outcome data to be collected to inform
coordinated medical care and patient self-management.
The trial found depression in 34% of patients with CHD
or T2DM, and demonstrated that the practice nurse-led,
collaborative care model was both feasible and accepta-
ble.
The role of practice nurses in collaborative care of chronic
disease is being investigated both in Australia and over-
seas. [14-16]. The features of the True Blue study are that
the programme
￿ routinely screens for depression;
￿ monitors depression severity over time for partici-
pating patients;
￿ uses the existing work force and funding arrange-
ments to potentially make the model more widely
applicable;
￿ uses consultations with practice nurses that allow
collection of physiological measurements, monitoring
of lifestyle and mental health risks and setting of
patient goals; and
￿ is linked with appointments to the patient's usual
general practitioner (GP).
The present study works with this subset of patients who
have co-morbid depression and aims to demonstrate
improved clinical outcomes for this higher-risk group
through measurements of physiological, mental health
and lifestyle parameters at regular intervals throughout
the study period. It will further test and implement this
collaborative care model that is focussed on the patient.
An important aspect is that patients, in collaboration with
the practice nurse, will develop up to three goals that they
feel will be able to help reduce their risk factors, thus mak-
ing patients active participants in their own health care.
The model is also intended to demonstrate how the care
of co-morbid depression, heart disease and diabetes can
be funded successfully using Australian Medicare Benefits
Schedule (MBS) Item numbers. It will develop trainingBMC Family Practice 2009, 10:46 http://www.biomedcentral.com/1471-2296/10/46
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programmes for PNs in screening, assessment and man-
agement of patients with co-morbid depression and heart
disease or diabetes, and evaluate the feasibility of PNs to
carry out screening and assessment.
Objectives of this study
The primary objective of this study is to determine
whether practice nurse-led collaborative care is better than
the usual method of GP-led episodic care for the manage-
ment of co-morbid depression in patients with heart dis-
ease or diabetes by testing whether there is an
improvement in the depression score at the end of the
study. The goal is to achieve a 50% reduction in that score.
It will also test whether it is a practical way to manage this
complex and increasing chronic-disease burden. It will
introduce an hour-long consultation with the practice
nurse in which patient goal setting forms an important
proactive part of the patient care. One key strategy is that
the patient outcomes will be reviewed every three months
over an entire year and patient goals altered accordingly.
Other objectives are to demonstrate that the model of care
can use existing clinical staff and be funded within current
Medicare arrangements, and that it can be used in large
and small practices across rural and urban settings.
Methods/design
This study is a cluster-randomised intervention trial in
which general practices were allocated either to an inter-
vention group in which nurse-led collaborative care is to
be undertaken or to the control group in which usual GP-
led care is to be continued. Ethics approval for the project
was obtained from Flinders University Social and Behav-
ioural Research Ethics Committee, approval number
4164. Figure 1 shows the flowchart of the TrueBlue study.
Survey forms
Patient Health Questionnaire (PHQ-9)
The PHQ-9 questionnaire will be used to measure and
monitor depression over time. It is self-administered, suit-
able for face-to-face and postal responses and for research.
Its brevity and reliability as a valid measure of depression
severity make it a useful clinical and research tool [17].
The form has nine questions that are simply scored from
0 (no problems) to 3 (problems nearly every day). Each of
these assesses various physiological and mood indicators
of depression, and are combined to form the total PHQ-9
score. Scores 5–9 indicate mild depression, 10–14 moder-
ate depression, 15–19 moderately severe, and scores
above 19 indicate severe depression.
SF36 (Version 2)
Health and lifestyle will be measured using version 2 of
the SF-36 questionnaire. This questionnaire is a multi-
purpose, short-form health survey that provides a profile
of health and well-being as well as a psychometrically-
based physical and mental health summary measures and
a preference-based health utility index [18]. This ques-
tionnaire provides a suite of generic measures rather than
specific ones, but has proven to be useful in surveys of
general and specific populations in differentiating the
health benefits produced by a wide range of different
treatments.
The GP Management Plan (GPMP)
Critical to collaborative care in chronic-disease manage-
ment is a system that ensures the coordination of care
between the GP and other health-care providers and
assists patient self-management. This document, the GP
management plan (GPMP), was developed by the GGT
UDRH in collaboration with each of the practices in the
programme. The design of this multi-purpose document
enables it to serve the following functions, within the lim-
its of current electronic medical-record applications, with
minimum data entry:
￿ Provide a single template covering T2DM and CHD
diagnoses;
￿ List patient medical history;
￿ List medication used, including prescribed medica-
tion, aspirin and antidepressant use;
￿ Record physiological risk factors, including blood
pressure, weight, height, body-mass index (BMI),
waist circumference, microalbuminuria, lipid profile
and, for diabetic patients, HbA1c;
￿ Record lifestyle risks, including smoking, alcohol
consumption and exercise regime;
￿ Record the psychosocial risks and PHQ-9 depression
scores, including referrals to and consultations with a
mental-health worker;
￿ Checklist of preventative activities and targets rec-
ommended in National Heart Foundation and Diabe-
tes Australia guidelines;
￿ Individual patient goals, targets and agenda for
future consultations;
￿ List referrals to specialists, allied health and commu-
nity resources;
￿ Timetabled recall;
￿ Help practices complete the requirements to claim
Medicare rebates for care planning and diabetes cycle
of care; andBMC Family Practice 2009, 10:46 http://www.biomedcentral.com/1471-2296/10/46
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￿ Automatically generate de-identified data for
research and audit.
The GPMP includes an office-use summary table contain-
ing only data that are relevant to the research. These data
are identified only by a unique patient ID number
assigned by the patient's practice. No personal details are
forwarded to the research team. The patient information
in the GPMP office-use summary is listed in the Appendix.
Sample size
Nine intervention and nine control practices, each with 50
patients, will be required to detect a minimum 2-point
reduction in the PHQ-9 score at the 0.05 significance level
with 80% power. These patient and practice numbers
were determined assuming a change in PHQ-9 with stand-
ard deviation of 5.1 as observed in the pilot study [13], a
drop-out of no more than 33%, and an intra-cluster corre-
lation of 0.04. Note that detecting a 2-point reduction in
the overall PHQ-9 score is a more-stringent requirement
than this project's objective of achieving a 50% reduction
in that score.
Practice recruitment
Practices from three regions (Adelaide, inner Melbourne
and the NSW Northern Rivers area) were selected to
Flowchart of the TrueBlue project Figure 1
Flowchart of the TrueBlue project.
THE TRUEBLUE PROJECT
EIGHTEEN GENERAL PRACTICES
(From Northern Rivers, Melbourne, Southern and Western Adelaide)
Randomly allocated to:
TREATMENT
GENERAL PRACTICES
CONTROL
GENERAL PRACTICES
IDENTIFY AT RISK PATIENTS WITH DEPRESSION
and CHD or DIABETES
Nurse training workshop
PROVIDE
COLLABORATIVE CARE
PROVIDE USUAL CARE
(for first 6 months)
Nurse training workshop
PATIENTS INVITED TO FIRST VISIT 
(Four patients per week to a total of 50 patients)
PRACTICE NURSE ASSESSES AND SCREENS PATIENTS FOR RISK
Physiological
Lifestyle
Psychosocial
PRACTICE NURSE (PN) PREPARE PLAN(S)
PN works with patient on setting individual goals
PN drafts GP Management Plan and Mental Health Care Plan including Goal Setting
Referral to other health practioners for treatment as required
GP reviews/changes/endorses GP Management and Mental Health Care Plans
FOLLOW−UP VISITS EVERY 3 MONTHSBMC Family Practice 2009, 10:46 http://www.biomedcentral.com/1471-2296/10/46
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undertake the study. Practices were selected from these
regions using a range of criteria, including size and capac-
ity, and assessable electronic medial records capable of
generating an electronic registry of patients with CHD or
T2DM. Practices also needed to have a PN available to
lead the collaborative care.
Information about the study was circulated to these prac-
tices to explain the benefits of the True Blue project to
their GPs, PNs and practice managers. These were fol-
lowed up with orientation evenings that provided further
detail. GPs who were interested in the project and who
were able to guarantee protected time for their PN(s) to
undertake the collaborative care were invited to join and
their clinics included in the project, until six practices
from each of the three regions had been selected.
Randomisation
Nine practices were randomly allocated to the interven-
tion group in which nurse-led collaborative care will be
undertaken. The remaining nine practices were allocated
to the control group in which the usual GP-led care will
continue for a period of six months. At the end of this
period, the control practices will be invited to implement
the practice nurse-led model of collaborative care and to
send practice nurses to a training workshop (see below).
Patient recruitment
Within each general practice, a mailing list of patients
with a diagnosis of CHD or T2DM is generated. Patients
who are either under 18 years of age or in residential care
are excluded from the study. Eligible patients are added to
the master list as potential participants in the programme
and assigned a unique identification (ID) number. All
documentation or data forwarded to the researchers for
the patient is identified only by this unique ID number.
Personal details of patients, including names and
addresses, are retained by the clinic concerned.
An information package is posted from the practice to
each of these patients. It includes a standardised personal
letter from their GP explaining the study, information
brochures, a PHQ-9 questionnaire, and a consent form
indicating the patient's willingness to participate in the
programme. Each patient is asked to complete and return
the PHQ-9 and consent forms. The returned PHQ-9 ques-
tionnaire from consenting patients is examined to identify
PHQ-9 scores above 5, indicating presence of at least mild
depression. These patients are invited to join the study.
Patients who do not respond to the first mail-out are sent
a reminder letter approximately two weeks later inviting
them to participate, with further reminder letters, tele-
phone calls and personal invitations when visiting clinics,
until 50 patients have been recruited.
Inclusion and exclusion criteria
Practices with an electronic-medial-records system capa-
ble of generating an electronic registry of patients with
CHD or T2DM and with a PN available to lead the collab-
orative care are eligible to participate. Patients with either
T2DM or CHD are eligible to participate, provided that
they were over 18 years of age and are not in residential
care.
Practice nurse training workshop
A two-day training workshop was organised for the PNs
from the intervention practices to prepare them for
enhanced roles in nurse-led collaborative care. This work-
shop introduced the rationale of the collaborative care
model before presenting a range of topics to prepare PNs
for their additional roles. Topics presented in the work-
shop include:
￿ Screening for depression;
￿ Identification and measurement of physiological
risk factors such as high cholesterol, blood pressure,
blood glucose and central obesity;
￿ Lifestyle risk factors such as smoking, poor nutrition,
alcohol and physical inactivity;
￿ Training to educate patients in diabetes and heart
disease risk reduction;
￿ Training in assisting patients with goal setting and
problem solving;
￿ Coordinating referrals and timetabled follow up;
and
￿ Preparing the draft GP Management Plan.
Intervention programme
Each patient's session with the PN is scheduled to take
approximately one hour. During their initial (baseline)
session, each patient completes the SF36v2 questionnaire
and a new PHQ-9 questionnaire if the earlier one is more
than two weeks old. Their current medication list is also
updated to include over-the-counter products. The PN
assesses the patient, beginning by measuring their physio-
logical parameters, reviews the potential risk factors (bio-
logical, lifestyle, psychological) and develops up to three
lifestyle goals with the patient that he/she feels are achiev-
able in reducing his/her risk factors. The SNAP (Smoking,
Nutrition, Alcohol, Physical exercise) assessment http://
www.racgp.org.au/guidelines/snap, for example, can be a
useful guide. The PN and patient identify possible barriers
to achieving these goals and discuss enabling methods
that may overcome these barriers. The PN may also sug-BMC Family Practice 2009, 10:46 http://www.biomedcentral.com/1471-2296/10/46
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gest other professional services that may assist the patient
in improving his/her outcomes, such as a dietician or
counsellor. The PN may also supply educational material
to assist patients in understanding their condition and
meeting their goals. The PN completes the consultation by
setting the review appointment date, and identifying any
future tests that may be required beforehand. Patients
responding positively to the ninth question on the PHQ-
9, which assesses suicidal ideation, are immediately
referred to their GP. The practice nurse consultation is
scheduled to take about 45 minutes to complete. The
remaining 15 minutes is set aside to add these data to the
GP management plan (GPMP) before this is forwarded to
the GP. The draft GPMP document becomes a readily
accessible information support document for medication
changes and referrals. The GP completes the plan during
the consultation with the patient, providing the patient
with a copy of the completed GPMP document.
An important aspect of this collaborative care programme
is that patients are recalled systematically to monitor the
progress of their care. Another important aim is that the
nurse-led care can be completely self-funded using the
normal Medicare item numbers. Consequently, a thir-
teen-week interval was chosen as the recall period. The
recall visits are booked at the time of the previous visit.
During each review, patients will complete a new PHQ-9
questionnaire so that any changes to their mental health
can be monitored. Additional therapies or new strategies
can be considered during the consultations if the PHQ-9
score has not improved by at least 50% or dropped below
5. These strategies may include changing or adding medi-
cation or referral to a mental health professional. The PN
and patient then re-evaluate the goals from the previous
consultation. In the second (6-month) and fourth (12-
month) consultations, the patient will complete a new
SF36v2 form to assess changes in quality of life.
Data collection, verification and analysis
The research team includes a practice facilitator in each
region to offer support to practice nurses and to monitor
progress of the research programme. Monthly teleconfer-
ence meetings are held to identify common issues and
problems so that these can be addressed in a timely man-
ner.
Data collection begins in the practice with the PNs enter-
ing patient data into their respective practice electronic
databases, and then using these data to generate the
GPMP for each patient. The GPMP includes a de-refer-
enced, office-use-only summary table, shown in the
Appendix, with the data that are relevant to the research.
The PN copies the de-identified summary table from the
practice database into a data-validation spreadsheet sup-
plied by the GGT UDRH. The spreadsheet checks the
GPMP summary table for completeness, consistency and
accuracy. It highlights missing data and data that lie out-
side expected ranges that may be a result of typographical
errors. These provide a warning to allow the PNs to
recheck the data. Once verified, the PN forwards the vali-
dated GPMP summary data to the research team at GGT
UDRH, where a final check is performed before their data
are added to the master database. 
Independent groups t-tests and χ2 tests will be used with
baseline measures to check intervention and control for
any imbalance. Clinical measures and changes (between
baseline and follow-up) in outcomes of participants will
be compared with measurements of controls. The differ-
ence in the change in the continuous outcome measures
(particularly the PHQ-9 score) between the two studied
groups will be analysed using linear mixed models, treat-
ing "group" as a between-subject factor and "time" as a
within-subject factor. Categorical outcome variables will
be analysed using generalised estimating equations
(GEE), following the same approach. The intention-to-
treat principle will be adhered to, and sensitivity analysis
will also be carried out. Regression analysis, including
logistic regression, will be used to identify baseline varia-
bles that predict successful outcomes and adherence.
Acceptability interviews
On completion of the programme, a series of structured
interviews with PNs and GPs will be undertaken to discuss
the nurse-led collaborative care model and its perceived
strengths, weaknesses and barriers. We will examine how
the role of the PN is changed, concentrating on confi-
dence and expertise in leading the new model of care. We
will examine how the GPs have or have not accepted the
model of care and determine any problems and issues that
may have arisen in implementing the model.
We will also undertake interviews with a randomly
selected list of patients. These interviews will be con-
ducted by telephone to preserve patient anonymity. We
will discuss the perceived strengths and weaknesses of the
collaborative care model from the patient's point of view,
and examine barriers and enablers to the model.
Discussion
The strength of this programme is that it provides a full
package of chronic disease management techniques,
based on Wagner's chronic disease management (CDM)
model [19]. The programme involves reading the practice
electronic medical record to generate a master list of
patients who satisfy the prescribed selection criteria. These
patients are invited to begin the collaborative care process,
and are systematically recalled at the prescribed review
period. The collaborative care process is audited using
patient feedback. Medicare funding will mean practices
are remunerated for the more intense patient interven-
tion.BMC Family Practice 2009, 10:46 http://www.biomedcentral.com/1471-2296/10/46
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The programme uses the existing workforce but involves
an enhanced role for the practice nurses and so is applica-
ble for wider roll out in using this potentially under-uti-
lised resource. The practice nurses gain enhanced skills in
the CDM set up and management that will be a useful
model for patients with other chronic diseases.
A full range of outcome measures is reported and added
to the electronic database. Consequently, practices will
know what happens to patients (process of care) and will
be able to identify changes in classic risk factors, depres-
sion symptoms and affordability within the Australian
health system.
We note that practices need to be large enough to have
available a practice nurse to participate in the programme.
This study is only funded for 15 months of data collection
but early feedback from participating practices indicates
they are likely to choose to continue this nurse-led collab-
orative model of care beyond the lifetime of the research.
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Appendix
The patient information provided in the GP Management
Plan office-use summary section is shown below.
Patient's True Blue Record Number
GPMP or REVIEW
Diagnosis (CHD/T2DM/Both)
Date of birth
Gender
Ethnicity (ATSI) status
Patient speaks language other than English at home
Date of this service
Date of previous GP Management Plan (if prepared)
Date of last GP Mental Health Care Plan (if done)
SF36v2 completed
Smoking
Alcohol consumption
Current weight
Height
BMI
Current BP
Current waist circumference
Patient exercises 30 minutes per day, 5 days per week?
Total Cholesterol
Triglycerides
LDL
HDL
Previous episode of depression or anxiety?
Type of current treatment
Currently taking antidepressant medication?
Referred to Mental Health Worker?
Currently seeing Mental Health Worker?
Has the patient been referred to an exercise program?
Is the patient attending an exercise program?
PHQ9 total score
PHQ9 difficulty score
Proposed review date
Aspirin use
Goal 1 for the next three months
Goal 2 for the next three months
Goal 3 for the next three months
Previous goal 1 (Met/Partially met/Re-negotiated)Publish with BioMed Central    and   every 
scientist can read your work free of charge
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Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
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Previous goal 2 (Met/Partially met/Re-negotiated)
Previous goal 3 (Met/Partially met/Re-negotiated)
T2DM only
HbA1c
Micoalbuminuria results (normal/raised)
Month of last professional eye exam
Date of last recorded foot check
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